I now have comprehensive information to deliver a thorough clinical answer. Here is the full structured response:
Ratol (Aluminium Phosphide) Poisoning - Clinical Management
What is Ratol?
"Ratol" is the common street name for aluminium phosphide (AlP) tablets used as a rodenticide/grain fumigant, widely available in South Asia. When ingested, AlP reacts with gastric acid and moisture to release phosphine gas (PH₃), a potent mitochondrial poison that inhibits cytochrome c oxidase, disrupts oxidative phosphorylation, and causes profound multi-organ failure.
Key facts:
- Lethal dose: 150-500 mg for adults (1 tablet = ~3 g AlP)
- Mortality: ~54% even with treatment (pooled data from 3449 Indian patients, Kumar et al., 2025)
- Intentional ingestion accounts for ~94% of cases
- There is no specific antidote
Step 1: Immediate Assessment and Resuscitation (CAB First)
On Arrival - Do These Simultaneously:
- Remove from source - take patient to fresh air/well-ventilated area; phosphine is absorbed cutaneously too
- Skin decontamination - remove clothes, wash skin with soap and water
- Airway - secure with endotracheal intubation if GCS is reduced or respiratory distress is present; prevent aspiration pneumonitis
- Breathing - high-flow supplemental oxygen; prepare for mechanical ventilation
- Circulation - establish central venous access (peripheral IV is acceptable initially); give 0.9% normal saline bolus for hypotension; start vasopressors (norepinephrine/dopamine) early - hypotension is severe and refractory
- Do NOT induce vomiting - this increases phosphine gas inhalation risk
- Do NOT give milk or alkaline solutions orally before confirming gastric decontamination plan
Step 2: Investigations
Run these urgently and simultaneously:
| Investigation | Why |
|---|
| ECG (continuous monitoring) | Arrhythmias are common: ST changes, VT, VF, complete heart block |
| Echocardiography | Detects early myocardial depression/cardiogenic shock |
| Arterial Blood Gas (ABG) | Metabolic acidosis is almost universal; guides bicarbonate therapy |
| Blood glucose | Hyperglycemia at admission = poor prognostic marker |
| Serum electrolytes (Na, K, Ca, Mg) | Hypomagnesemia may worsen arrhythmias; hypermagnesemia also described |
| Complete blood count (CBC) | Assess for intravascular hemolysis |
| Liver function tests (LFTs) | Hepatotoxicity common |
| Renal function tests / creatinine | Acute kidney injury/renal failure |
| Chest X-ray | Aspiration pneumonitis, pulmonary edema |
| Serum lactate | Reflects tissue hypoxia / mitochondrial dysfunction |
| Coagulation profile (PT/INR, APTT) | DIC may develop |
| Methemoglobin level (co-oximetry) | Cyanosis not responding to O₂ suggests methemoglobinemia |
| Serum amylase/lipase | Pancreatitis |
Confirmatory test for AlP (forensic/if uncertain):
- Filter paper moistened with silver nitrate turns black in the presence of phosphine
- Add a drop of ammonium molybdate - paper turns blue (confirmation)
- Gold standard: gas chromatography with nitrogen-phosphorous detector on gastric content/viscera
Step 3: Gastrointestinal Decontamination
Act within 6 hours of ingestion if possible.
- Gastric lavage with coconut oil or liquid paraffin (50-100 mL): Oil inhibits phosphine release from AlP tablets - this is a key intervention. Coconut oil has the strongest evidence (Shadnia et al.; Hafez et al. meta-analysis 2024)
- After oil lavage, perform standard water/saline lavage
- Sodium bicarbonate (SBC) added to lavage fluid may further reduce phosphine liberation
- Activated charcoal (1 g/kg): has limited efficacy for AlP but can be tried if patient is alert and not vomiting; dose - child: 25-50 g
- Do NOT use cathartics routinely
Step 4: Specific/Adjunctive Treatments
Antioxidants (reduce oxidative stress - key mechanism of toxicity):
| Drug | Dose | Evidence |
|---|
| N-acetylcysteine (NAC) | IV: 150 mg/kg loading, then 50 mg/kg over 4h, then 100 mg/kg over 16h | RCT showed reduced mortality, ICU stay, intubation need |
| Vitamin E | 400 mg IM or oral, 8-hourly | Clinical trial data - reduces mortality |
| Glutathione | IV infusion | Experimental; used in some centers |
Cardiovascular Support:
- Vasopressors: Norepinephrine first-line for refractory hypotension
- Inotropes: Dobutamine for cardiogenic shock component
- Glucose-Insulin-Potassium (GIK) infusion: Has shown mortality benefit in clinical studies - acts as metabolic cardioprotection
- Digoxin + Glucagon combination: Reported as beneficial in some case series (for refractory hemodynamic compromise)
- ECMO (Extracorporeal Membrane Oxygenation): Consider early in centers with availability - has shown survival benefit in severe cases (systematic review PMID 37387512)
- Magnesium sulfate: IV infusion - membrane stabilization, anti-arrhythmic, antioxidant. Evidence mixed; check Mg levels first to avoid hypermagnesemia
Metabolic/Acid-Base:
- IV Sodium bicarbonate: For metabolic acidosis - "aggressive acidosis correction" protocol significantly improved outcomes (30% vs 55% mortality reduction in one study)
- Insulin (for stress hyperglycemia): Target glucose <180 mg/dL
Renal Replacement:
- Hemodialysis/peritoneal dialysis: Not effective for removing phosphine itself, but indicated for renal failure, severe acidosis, or fluid overload
- Peritoneal dialysis has been used successfully in cases with severe metabolic acidosis
Methemoglobinemia (if present):
- Methylene blue 1% solution: 2 mg/kg IV over 5 minutes - can repeat if cyanosis persists
Step 5: Monitoring in ICU
- Continuous cardiac monitoring - fatal arrhythmias can occur at any time in first 24-48 hours
- Serial ABGs every 2-4 hours
- Hourly urine output
- Serial echocardiography for cardiac function
- Blood glucose every 2-4 hours
Step 6: Prognostic Markers (Poor Prognosis)
- Severe hypotension at admission (most common presentation: ~78% of patients)
- Severe metabolic acidosis (pH <7.1)
- Hyperglycemia at admission
- Large ingested dose (>1.5 g - though survivors reported even at 9 g)
- Delayed presentation (>6 hours)
- Refractory arrhythmias
Step 7: Since This is a 16-Year-Old Female
Given the patient's age and that ~94% of AlP poisonings are intentional (suicidal), mandatory psychiatric evaluation is needed once medically stable. Assess for:
- Depression and suicidal ideation
- Underlying psychosocial stressors
- Family dynamics and safety at home
- Arrange follow-up with adolescent psychiatry before discharge
Summary Algorithm
Arrival → CAB Resuscitation
↓
Remove from exposure + Skin decontamination
↓
Urgent investigations (ECG, ABG, electrolytes, glucose, LFTs, RFTs, CBC)
↓
Gastric lavage with coconut oil/liquid paraffin (within 6 hours)
↓
Vasopressors + Inotropes for hemodynamic support
↓
NAC + Vitamin E (antioxidants)
↓
IV Sodium bicarbonate for metabolic acidosis
↓
GIK infusion + Magnesium sulfate (check levels)
↓
ICU admission - continuous cardiac monitoring
↓
Dialysis if renal failure/severe acidosis
↓
ECMO if refractory cardiorespiratory failure
↓
Medical stabilization → Psychiatric evaluation
Important note: There is no proven antidote for AlP/Ratol poisoning. Management is entirely supportive. Despite aggressive therapy, mortality remains ~50%. Early presentation, aggressive resuscitation, oil-based gastric lavage, and antioxidant therapy offer the best chance of survival (Sobh et al., Crit Rev Toxicol 2023 [PMID 37387512]).